Abiopharma

Cybin - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040

10 Barrel Pub Beer Taps Big Buck Hunter for Epic Cheap Fun Hunting SZN – Limited Edition Cans, Dive Bar Prizes, and $10,000 Arcade Giveaway Ignite Pacific Northwest

Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good

Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update